BioSpace News Archive

Canadian pharmaceutical company SaNOtize Research & Development Corp., and Glenmark Pharmaceuticals Limited, a global, innovation-driven pharmaceutical company, announced successful results of Phase 3 clinical trials and approval from India’s drug regulator for the treatment of adult patients with COVID-19 who have a risk of progression of the disease.

MRIdian will be the First MRI-guided Radiation Therapy System at Krukenberg Cancer Center.

Henry Schein, Inc. announced today that the Company will present at the following two virtual investor events in February. Baird 2022 Sustainability Conference on February 23, 2022, at 2:20 p.m. Eastern time and Jefferies 2022 Dental Summit on February 24, 2022, at 1:00 p.m. Eastern time.

CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2021.

Pardes Biosciences, Inc. announced that a virtual investor event will be hosted by the company’s management team following the presentation of clinical data from the ongoing PBI-0451 Phase 1 trial at the 29th Conference On Retroviruses And Opportunistic Infections 2022.

Medicenna Therapeutics Corp., a clinical stage immuno-oncology company, announced its financial results and operational highlights for the quarter ended December 31, 2021.

PolyPid Ltd., a Phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology, provided a corporate update and reported financial results for the three months and full-year ended December 31, 2021.

Purple Biotech Ltd., a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, announced financial results for the year and the six months ended December 31, 2021.

Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, announced that management will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on February 16, 2022 at 9:20 a.m. ET.

Mevion Medical Systems and Proton International announce the selection of the MEVION S250i Proton Therapy System with HYPERSCAN Pencil Beam Scanning (PBS) to equip the UT Health San Antonio Proton Therapy and Research Center.